Event Type
Disclosure
Voluntary
Variant
8-K
, including Exhibit 99.1 and Exhibit 99.2 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Excha
. Other Events. On December 17, 2025, the Company issued a press release announcing initial data from its Phase 1a SAD trial of TH103 in treatment-naïve patient
. Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description 99.1 Press Release, dated December 17, 2025 99.2 Presentation, dated December 17, 202